Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources

FRANKFURT, June 6 (Reuters) - German healthcare supplier Fresenius and British engineering company Smiths Group have emerged as the final bidders for Pfizer's infusion pumps business in a possible deal worth close to $1.5 billion, people familiar with the matter said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.